###  {data-menu-title="IBD Network"}

[Inflammatory Bowel Disease: an ODE model]{.slide-title2}

:::: {.r-stack}
::: {.fragment .fade-out}
```{mermaid}
flowchart LR

      subgraph Macrophages
      A["Inactivated Macrophage $$\,M_0$$"] --> B["Activated Macrophage $$\, M_1 M_2$$"]
      end
      
      subgraph Cytokines
      B <-->|"Inflammation"| C["TNF-$$\alpha$$"]      
      B <--> D["IL-10"]
      B <--> E["TGF-$$\beta$$"]
      B --> F["IL-6"]
      B --> G["IL-21"]
      B --> H["IL-4"]
      B --> I["IL-2"]
      B <--> J["IFN-$$\gamma$$"]
      J --> I      
      I --> D 
      D --x I
      end
      
      subgraph T cells      
      M["Th17"] x--x N["Treg"]
      K["Th1"] x--x L["Th2"]
      K --> J
      I <--> K
      L <--> H
      M <--> E
      N <--> E
      N <--> D
      C --x N
      N --x K & L
      J & H --x M
      end
      
    linkStyle 11,12,13,20,21,22,23,24 stroke:red, stroke-width:5px;
    linkStyle 0,1,2,3,4,5,6,7,8,9,10,14,15,16,17,18,19 stroke:green, stroke-width:5px;
```

Depiction of the ODE Network of immune cells and cytokines' interactions. Reproduced from [Fig.1, \@lo2016po](https://pmc.ncbi.nlm.nih.gov/articles/PMC5289480/figure/pone.0170865.g001/)
:::

::: {.fragment .fade-in-then-out}
![Original rendering on [`Mermaid Edit`](https://mermaid.live/edit)](images/mermaid_original_graph.png){width="75%"}
:::

::::

::: aside
`SBMLNetwork` framework, from @heydarabadipour2025, automates the rendering of biochemical models, spanning from Pathways to Metabolic Models and Flux-diffusion process. Available as the open-source Python package [`SBMLNetwork`](https://github.com/sys-bio/SBMLNetwork).
:::

###  {.scrollable data-menu-title="IBD ODEs"}

[Main classes of ODE models, ordered by increasing complexity]{.slide-title2}[^1-ibd-model-1]

[^1-ibd-model-1]: [All these equations adhere to the **rate-law** principle, see @tip-mass-action.]{.slide-title2}

::::: {.panel-tabset}

#### **Linear Equations**

-   Constant fluxes, and/or **Production and decay model**.

-   *Example*: secretion of IL-2 by Th1 cells minus IL-2 decay, in @eq-cytokine-variation:

    -   $I_2$: cytokine concentration
    -   $T_1$: **substrate**, cell-type abundance
    -   $\nu_{21}$ and $\delta_2$: **parameters** of the model, respectively production rate and decay rate

$$
\frac{dI_2}{dt} = \nu_{21} T_1 - \delta_2 I_2
$$ {#eq-cytokine-variation}

#### **Michaelis-Menten**

:::: {.r-stack}

::: {.fragment .fade-out}
-   **Catalytic activation**: used when a the speed of the reaction is driven by a limiting resource:

-   @lo2016po models reactions' kinetics with a **Michaelis-Menten** process.

-   **Example**: differentiation of $M_0$ macrophages into $M_1$ functional macrophages driven by $TNF-\alpha$, see @eq-Michaelis-Menten:

    -   $f_1$: (optional), basal activation of $M_0$
    -   $M_0$: undifferentiated **substrate**
    -   $I_{\alpha}$: modifier or **catalyst** of the reaction (e.g., antigen, cytokine precursor)
    -   $\sigma_{M_{\alpha}}$: **maximum rate** signalling or activation rate.
    -   $\zeta _{M_{\alpha}}$: **half-saturation** constant

$$
\frac{dM_1}{dt} = \left(f_1 + \frac{\sigma_{M_{\alpha}} I_{\alpha}}{\zeta _{M_{\alpha}} + I_{\alpha}}\right) M_0
$$ {#eq-Michaelis-Menten}
:::

::: {.fragment .fade-in-then-out}
-   **Uncompetitive inhibition**, formula is the inverse of the **catalytic activation**.

-   **Example**: alteration of IL-$21$ activation efficiency by the IL-4 interleukin, in @eq-inhibition:

    -   $M$: the macrophages subset
    -   $\zeta_4$: Michaelis half-constant for inhibition activity
    -   $I_{21}$ and $I_4$: Activator and Inhibitor concentration, respectively

$$
\frac{dT_{17}}{dt} = M \frac{1}{1 + \frac{I_4}{\zeta_4}}
$$ {#eq-inhibition}
:::

::::

#### **Homoeostatic**, Regulatory Models

-   Complex and intertwined network of positive and negative **Feedback loops**.
-   *Example*: **Differentiation** of T-17 population is primarily driven by **macrophages induction**.
-   However, the overall efficiency is regulated by a complex balance of cytokines activation and repression, see @fig-T17-regulation:

![Complex regulatory mechanism of $T_{17}$ immune cells, from @lo2016po, Eq.14. Macrophages induction is enhanced by interleukin $I_{\beta}$ in conjunction with $I_{21}$ and $I_6$, but inhibited by both interleukins $I_4$ and $I_{\gamma}$. Finally, a natural death of the cells occurred.](images/T17_regulation.png){#fig-T17-regulation}

:::::

. . .

[Unrepresented ODE equations include **Logistic Growth Models** (used for population dynamics in which *crowding effects* matter), **Hill** equations (controlling the steepness of feedback loops), or **Competitive** inhibitions.]{fg="red"}

###  {.scrollable data-menu-title="IBD ODEs II"}

[All ODE equations adhere to the **rate-law** principle, see @tip-mass-action.]{.slide-title2}

::: {#tip-mass-action .callout-tip collapse = "true" title="Mass-action principle"}

The following **mass-action** reaction (@eq-mass-action): 

$$
aA + bB \rightarrow P
$$ {#eq-mass-action}

adheres to the following **rate law**(@eq-rate-law)[^1-ibd-model-2]

[^1-ibd-model-2]: The **mass-action principle** states that the rate of a chemical reaction is proportional to the product of the concentrations of the reactants, raised to the power of their **stoichiometric coefficients**.

$$
\text{Rate} = k [A]^a [B]^b
$$ {#eq-rate-law}

:::

. . .

<br>

-   80 pre-defined functions in `COPASI`, from basic constant fluxes to complex competitive enzymatic reactions
-   Feature for providing user-defined functions
-   **Critical**: identify if the reaction is *reversible* or *irreversible* (uni-directional)
-   **Critical 2**: assign each element of the reaction one of these values, `parameter`, `modifier`, `product` or `substrate`.
